亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Feline Calicivirus Vaccine

技術優勢

hFCV strains can be used in a new generation of vaccines to produce a much broader spectrum of immunity. More broadly reactive FCV vaccines, immunizing against both common and hemorrhagic strains of vaccine, will provide a new market opportunity.

技術應用

The FCV vaccine can be used in accordance with routine vaccines as well as in vaccination clinics and veterinarian hospitals in order to fight certain viruses and protect against new as well as old strains.

詳細技術說明

Feline calicivirus (FCV) is a common pathogen in multiple cat environments such as shelters and catteries. FCV infection can cause a variety of usually self-limiting signs including fever, upper respiratory signs, acute or chronic oral disease, limping, and occasionally pneumonia. Over the last decade, numerous outbreaks of a highly fatal hemorrhagic form of FCV infection have been observed worldwide. This form of FCV infection often comes from young shelter cats and spreads rapidly by indirect and direct contact to older well-vaccinated household pet cats. Laboratory studies have confirmed these hemorrhagic strains to be resistant to current FCV vaccines. The best way to protect feline populations against this highly fatal form of FCV infection is via vaccines that include a broader immunity. Researchers at the University of California, Davis are proud to offer an invention relating to a vaccine against infections with hemorrhagic feline calicivirus (hFCV). This invention involves the incorporation of particular strains of hFCV into a new generation of vaccines. This invention is available for licensing on a non-exclusive basis.

附加資料

Patent Number: US7309495B2
Application Number: US2003388837A
Inventor: Foley, Janet E. | Hurley, Kate | Pedersen, Niels C.
Priority Date: 14 Mar 2003
Priority Number: US7309495B2
Application Date: 14 Mar 2003
Publication Date: 18 Dec 2007
IPC Current: C12N000700 | A61K0039125 | C07K001408 | C12N000701 | C12N000704 | A61K003900
US Class: 4242161 | 4352351
Assignee Applicant: The Regents of the University of California
Title: Hemorrhagic feline calicivirus
Usefulness: Hemorrhagic feline calicivirus
Summary: The immunogenic composition is useful as a vaccine for immunizing a viral infection caused by a hemorrhagic feline calicivirus (hFCV).
Novelty: New immunogenic composition comprises an amount of a hemorrhagic feline calicivirus (hFCV), useful as a vaccine for immunizing against a hemorrhagic feline calicivirus